Aktiesnakken — November 2009
-
jeg kan oplyse at Helle er ude af office 25-27
-
tænk at vi sidder med skrammel efter godkendelse, det er næsten ikke til at bære endisge forstår
-
jeg har de skøreste mails på folk der tro genmab bliver opkøbt i november....
-
der er ingen fonde der har genmab
-
men jeg tror der er massivt short salg i den
-
læste at nogen havde svært ved at levere aktierne
-
hya det amerikanske biotek indeks er steget 33% i år genmab er faldet 66%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind